Health
Multi-center Phase I study of anti-VISTA opens for patient enrollment – News-Medical.Net
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, no…
Reviewed by Emily Henderson, B.Sc.Oct 7 2020
Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) will serve as one of the lead institutions for a new multi-center clinical trial of anti-VISTA, now open and recruiting for patient enrollment. The trial is a Phase I study of CI-8993, an anti-VISTA (V-domain Ig Suppressor of T-cell Activation) antibody, in adult patients with advanced solid tumors.
VISTA is a checkpoint regulator whose function is to prevent activation of the immu…
-
Noosa News24 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Business23 hours ago3 steps to take to build a $1,000 monthly passive income
-
Noosa News24 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
General18 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats